{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:22:49Z","timestamp":1793064169627,"version":"4.5.0"},"reference-count":247,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.jhep.2009.04.009","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T08:00:30Z","timestamp":1244620830000},"page":"237-267","source":"Crossref","is-referenced-by-count":1479,"title":["EASL Clinical Practice Guidelines: Management of cholestatic liver diseases"],"prefix":"10.1016","volume":"51","author":[{"name":"European Association for the Study of the Liver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2009.04.009_bib1","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2009.04.009_bib2","series-title":"Textbook of hepatology: from basic science to clinical practice","first-page":"1481","article-title":"Intrahepatic cholestasis","author":"Chazouill\u00e8res","year":"2007"},{"key":"10.1016\/j.jhep.2009.04.009_bib3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2007.05.008","article-title":"Diagnosis and management of cholestatic liver disease","volume":"5","author":"Heathcote","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM199609263351301","article-title":"Complications of endoscopic biliary sphincterotomy","volume":"335","author":"Freeman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2009.04.009_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4065\/73.3.285","article-title":"Idiopathic adulthood ductopenia: an update","volume":"73","author":"Ludwig","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhep.2009.04.009_bib6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","article-title":"Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines","volume":"31","author":"Heathcote","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib7","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2009.04.009_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2007-979469","article-title":"Interpreting serological tests in diagnosing autoimmune liver diseases","volume":"27","author":"Invernizzi","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2009.04.009_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.jhep.2009.04.009_bib11","first-page":"106","article-title":"Primary biliary cirrhosis: diagnosis, pathology and pathogenesis","volume":"59","author":"Scheuer","year":"1983","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jhep.2009.04.009_bib12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis","volume":"3","author":"Beuers","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib13","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group","volume":"324","author":"Poupon","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2009.04.009_bib14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"19","author":"Heathcote","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib15","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis","volume":"106","author":"Lindor","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib16","first-page":"759","article-title":"A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"22","author":"Combes","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","article-title":"Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver","volume":"32","author":"Pares","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib18","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1053\/jhep.2000.20240","article-title":"The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis","volume":"32","author":"Corpechot","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib19","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2009.04.009_bib21","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/j.1572-0241.2007.01235.x","article-title":"Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses","volume":"102","author":"Gong","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1572-0241.2006.00634.x","article-title":"Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials","volume":"101","author":"Shi","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(05)72401-6","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"355","author":"Lindor","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2009.04.009_bib24","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0168-8278(99)80136-6","article-title":"Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial","volume":"30","author":"Angulo","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib26","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","article-title":"Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients","volume":"101","author":"ter Borg","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib29","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.1840100405","article-title":"A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss","volume":"10","author":"Mitchison","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(96)80327-8","article-title":"Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis","volume":"25","author":"Leuschner","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib31","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0016-5085(99)70351-3","article-title":"Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial","volume":"117","author":"Leuschner","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20646","article-title":"Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial","volume":"41","author":"Rautiainen","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib33","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.510310209","article-title":"Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid","volume":"31","author":"Angulo","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/jhep.2003.50266","article-title":"Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis","volume":"38","author":"Hempfling","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib35","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0016-5085(93)90422-9","article-title":"Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial","volume":"104","author":"Lombard","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/gast.1999.0029900400","article-title":"Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial","volume":"117","author":"Hendrickse","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-8278(97)80294-2","article-title":"The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone","volume":"27","author":"Gonzalez-Koch","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib39","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep.20897","article-title":"Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis","volume":"42","author":"Combes","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib40","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0016-5085(86)90183-6","article-title":"Randomized trial of chlorambucil for primary biliary cirrhosis","volume":"91","author":"Hoofnagle","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.mcg.0000177230.13770.4e","article-title":"Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid","volume":"39","author":"Talwalkar","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib42","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0016-5085(95)90696-7","article-title":"A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid","volume":"108","author":"Vuoristo","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib43","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.510240520","article-title":"A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA\u2013PBC Study Group","volume":"24","author":"Poupon","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.26.2.114","article-title":"Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis","volume":"26","author":"Neuberger","year":"1985","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.04.009_bib45","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1365-2036.2006.03164.x","article-title":"Systematic review and meta-analysis: d-penicillamine vs. placebo\/no intervention in patients with primary biliary cirrhosis\u2013Cochrane Hepato-Biliary Group","volume":"24","author":"Gong","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.04.009_bib46","doi-asserted-by":"crossref","unstructured":"The results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosis. A European multicentre study group. J Hepatol 1993;17:227\u201335.","DOI":"10.1016\/S0168-8278(05)80043-1"},{"key":"10.1016\/j.jhep.2009.04.009_bib47","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0168-8278(94)80092-8","article-title":"Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study","volume":"21","author":"McCormick","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib48","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/jhep.2000.18663","article-title":"Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid","volume":"32","author":"Angulo","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib49","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.21741","article-title":"Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid","volume":"46","author":"Stojakovic","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib50","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00042737-200212000-00014","article-title":"The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study","volume":"14","author":"Leuschner","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib51","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1872-034X.2007.00305.x","article-title":"The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: a prospective, multicenter study","volume":"38","author":"Iwasaki","year":"2008","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2009.04.009_bib52","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.20164","article-title":"Tamoxifen in treatment of primary biliary cirrhosis","volume":"39","author":"Invernizzi","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib53","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/j.1572-0241.2004.40741.x","article-title":"Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis","volume":"99","author":"Mason","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib54","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S1089-3261(03)00099-0","article-title":"Liver transplantation for primary biliary cirrhosis","volume":"7","author":"MacQuillan","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.04.009_bib55","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cld.2008.02.015","article-title":"Liver transplantation in primary biliary cirrhosis","volume":"12","author":"Milkiewicz","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.04.009_bib56","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2009.04.009_bib57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis\u2013autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib58","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib59","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1053\/jhep.2001.23316","article-title":"Autoimmune overlap syndromes","volume":"33","author":"Woodward","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib60","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2005-916322","article-title":"Overlap syndromes","volume":"25","author":"Beuers","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2009.04.009_bib61","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1572-0241.2002.05699.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system","volume":"97","author":"Heathcote","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib62","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib63","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1572-0241.2002.05703.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system","volume":"97","author":"Talwalkar","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib64","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","article-title":"Long term outcome and response to therapy of primary biliary cirrhosis\u2013autoimmune hepatitis overlap syndrome","volume":"44","author":"Chazouilleres","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib66","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s005350300006","article-title":"A scoring system for primary biliary cirrhosis and its application for variant forms of autoimmune liver disease","volume":"38","author":"Yamamoto","year":"2003","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.21229","article-title":"Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis","volume":"44","author":"Poupon","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib68","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","article-title":"The variant forms of autoimmune hepatitis","volume":"125","author":"Czaja","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2009.04.009_bib69","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.3748\/wjg.14.3368","article-title":"Overlap syndromes among autoimmune liver diseases","volume":"14","author":"Rust","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib70","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib71","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","article-title":"Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid","volume":"35","author":"Joshi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib72","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3748\/wjg.v12.i9.1362","article-title":"Budesonide induces complete remission in autoimmune hepatitis","volume":"12","author":"Csepregi","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib73","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/BF02064201","article-title":"Primary biliary cirrhosis\u2013autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A","volume":"40","author":"Duclos-Vallee","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2009.04.009_bib74","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MOG.0b013e3282f9e239","article-title":"An update on primary sclerosing cholangitis","volume":"24","author":"Maggs","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib75","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.3748\/wjg.v13.i41.5421","article-title":"Genetic epidemiology of primary sclerosing cholangitis","volume":"13","author":"Karlsen","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib76","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.21405","article-title":"Sclerosing cholangitis: a focus on secondary causes","volume":"44","author":"Abdalian","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib77","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.04.009_bib78","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gut.21.10.870","article-title":"Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology","volume":"21","author":"Chapman","year":"1980","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.04.009_bib79","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib80","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis","volume":"23","author":"Boberg","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib81","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib82","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib83","first-page":"43","article-title":"Surgical pathology of the syndrome of primary sclerosing cholangitis","volume":"13","author":"Ludwig","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2009.04.009_bib84","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/gut.39.4.594","article-title":"Increased gall bladder volume in primary sclerosing cholangitis","volume":"39","author":"van de Meeberg","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.04.009_bib85","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.11.019","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"48","author":"Said","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib86","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199504063321406","article-title":"Primary sclerosing cholangitis","volume":"332","author":"Lee","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2009.04.009_bib87","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiology.149.1.6412283","article-title":"Primary sclerosing cholangitis: findings on cholangiography and pancreatography","volume":"149","author":"MacCarty","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2009.04.009_bib88","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ajg.2008.161","article-title":"Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis","volume":"104","author":"Bangarulingam","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib89","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cgh.2005.10.007","article-title":"Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis","volume":"4","author":"Berstad","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib90","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0168-8278(00)80002-1","article-title":"Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis","volume":"33","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib91","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib92","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0168-8278(02)00036-3","article-title":"Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)","volume":"36","author":"Broome","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib93","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: a long-term follow-up study","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib94","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.51.5.731","article-title":"Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis","volume":"51","author":"Bjornsson","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.04.009_bib95","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep.22485","article-title":"A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults","volume":"48","author":"Gotthardt","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib96","first-page":"1415","article-title":"Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis","volume":"22","author":"Wilschanski","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib97","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/jhep.2003.50289","article-title":"Primary sclerosing cholangitis in children: a long-term follow-up study","volume":"38","author":"Feldstein","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib98","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib99","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1478-3231.2008.01726.x","article-title":"Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis","volume":"28","author":"Tanaka","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2009.04.009_bib100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC\u2013IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.04.009_bib101","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2009.04.009_bib102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer","volume":"26","author":"Broome","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2009.04.009_bib103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib104","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-2006-933562","article-title":"Primary sclerosing cholangitis and cholangiocarcinoma","volume":"26","author":"Lazaridis","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2009.04.009_bib105","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0168-8278(97)80356-X","article-title":"Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?","volume":"27","author":"Harnois","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib106","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2009.04.009_bib107","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib108","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/hep.21433","article-title":"Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation","volume":"44","author":"Prytz","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib109","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jhep.2006.05.010","article-title":"Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis","volume":"45","author":"Boberg","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0168-8278(90)90281-U","article-title":"Ursodeoxycholic acid for primary sclerosing cholangitis","volume":"11","author":"Chazouilleres","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib111","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/hep.1840140516","article-title":"Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study","volume":"14","author":"O\u2019Brien","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib112","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840160315","article-title":"Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial","volume":"16","author":"Beuers","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib113","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00365529409103626","article-title":"Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis","volume":"204","author":"Stiehl","year":"1994","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.jhep.2009.04.009_bib114","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis\u2013Ursodeoxycholic Acid Study Group","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2009.04.009_bib115","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib116","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jhep.2007.12.023","article-title":"High dose ursodeoxycholic acid for the treatment of primary sclerosig cholangitis is safe and effective","volume":"48","author":"Cullen","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib117","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib118","first-page":"378A","article-title":"Randomized, double-blind controlled trial of high-dose ursodeoxycholic acid for primary sclerosing cholangitis","volume":"48","author":"Lindor","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib119","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"134","author":"Tung","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2009.04.009_bib120","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2036.2005.02650.x","article-title":"The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis","volume":"22","author":"Wolf","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.04.009_bib121","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib122","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MEG.0b013e3281108068","article-title":"The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid","volume":"19","author":"Rudolph","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib123","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jhep.2004.01.002","article-title":"Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy","volume":"40","author":"Brandsaeter","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib124","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/00365520310005172","article-title":"Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients","volume":"38","author":"Boberg","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.gie.2007.07.042","article-title":"Complications after ERCP in patients with primary sclerosing cholangitis","volume":"67","author":"Etzel","year":"2008","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2009.04.009_bib126","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1572-0241.2007.01279.x","article-title":"Incidence rates of post-ERCP complications: a systematic survey of prospective studies","volume":"102","author":"Andriulli","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib127","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1055\/s-2000-7708","article-title":"Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis. Dutch PSC Study Group","volume":"32","author":"van den Hazel","year":"2000","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2009.04.009_bib128","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1572-0241.2004.04106.x","article-title":"Dominant strictures in patients with primary sclerosing cholangitis","volume":"99","author":"Bjornsson","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib129","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM200102083440604","article-title":"Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct","volume":"344","author":"Hammel","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2009.04.009_bib130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib131","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","article-title":"Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis","volume":"53","author":"Baluyut","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2009.04.009_bib132","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0016-5107(91)70618-4","article-title":"Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment","volume":"37","author":"Johnson","year":"1991","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2009.04.009_bib133","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0168-8278(97)80421-7","article-title":"Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study","volume":"26","author":"Stiehl","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib134","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0016-5107(97)70123-8","article-title":"Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis","volume":"46","author":"van Milligen de Wit","year":"1997","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2009.04.009_bib135","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1572-0241.2001.03690.x","article-title":"Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis","volume":"96","author":"Kaya","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib136","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/01.TP.0000113807.74942.D2","article-title":"Roux-en-Y choledochojejunostomy is the method of choice for biliary reconstruction in liver transplantation for primary sclerosing cholangitis","volume":"77","author":"Welsh","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2009.04.009_bib137","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1002\/lt.20948","article-title":"Recurrent primary sclerosing cholangitis: clinical diagnosis and long-term management issues","volume":"12","author":"Gordon","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2009.04.009_bib138","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.21337","article-title":"Primary sclerosing cholangitis: summary of a workshop","volume":"44","author":"LaRusso","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib139","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2009.04.009_bib140","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0016-5085(87)91082-1","article-title":"Primary sclerosing cholangitis in childhood","volume":"92","author":"el-Shabrawi","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib141","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1155\/1988\/218728","article-title":"Autoimmune chronic active hepatitis (lupoid hepatitis) and primary sclerosing cholangitis in two young adult females","volume":"2","author":"Minuk","year":"1988","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib142","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/BF01296509","article-title":"Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis","volume":"37","author":"Rabinovitz","year":"1992","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2009.04.009_bib143","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2007-1007301","article-title":"A 39 year old man with chronic hepatitis","volume":"14","author":"Lawrence","year":"1994","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2009.04.009_bib144","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-3476(94)70253-5","article-title":"Sclerosing cholangitis in children","volume":"124","author":"Debray","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2009.04.009_bib145","first-page":"1415","article-title":"Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis","volume":"22","author":"Wilschanski","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib146","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0168-8278(96)80266-2","article-title":"Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis","volume":"24","author":"Gohlke","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib147","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.1998.224_a.x","article-title":"Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases","volume":"93","author":"McNair","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib148","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.04.009_bib149","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis","volume":"33","author":"van Buuren","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib150","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib151","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib152","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/jhep.2002.37200","article-title":"Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome","volume":"36","author":"Abdo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib153","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00004836-199509000-00016","article-title":"Rapidly progressive sclerosing cholangitis following surgical treatment of pancreatic pseudotumor","volume":"21","author":"Stathopoulos","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib154","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(99)00603-0","article-title":"Sclerosing pancreato-cholangitis responsive to steroid therapy","volume":"354","author":"Erkelens","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2009.04.009_bib155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/00365520600664326","article-title":"Autoimmune pancreatocholangitis: a series of ten patients","volume":"243","author":"van Buuren","year":"2006","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.jhep.2009.04.009_bib156","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.21685","article-title":"Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature","volume":"45","author":"Bjornsson","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib157","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.21700","article-title":"Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis","volume":"46","author":"Umemura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib158","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.21697","article-title":"Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis","volume":"45","author":"Zen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib159","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib160","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1053\/jhep.2002.37136","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib161","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005176-199900001-00001","article-title":"Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group","volume":"28","author":"Sokol","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2009.04.009_bib162","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/hep.510230627","article-title":"Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis","volume":"23","author":"Colombo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib163","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/00365529709007686","article-title":"Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-up","volume":"32","author":"van de Meeberg","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib164","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.510270126","article-title":"A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease","volume":"27","author":"Lindblad","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(99)80166-4","article-title":"Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension","volume":"31","author":"Debray","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib166","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1053\/j.gastro.2005.08.052","article-title":"Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases","volume":"130","author":"Oude Elferink","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib167","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.95.1.282","article-title":"Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis","volume":"95","author":"de Vree","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2009.04.009_bib168","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/hep.21212","article-title":"Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport","volume":"44","author":"Paulusma","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib169","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/3034","article-title":"A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis","volume":"20","author":"Strautnieks","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2009.04.009_bib170","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep.21287","article-title":"Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency","volume":"44","author":"Knisely","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib171","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","article-title":"MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes","volume":"27","author":"Trauner","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2009.04.009_bib172","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-2001-19033","article-title":"Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases","volume":"21","author":"Jacquemin","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2009.04.009_bib173","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0016-5085(88)90301-0","article-title":"Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis","volume":"95","author":"Whitington","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib174","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jpedsurg.2007.10.055","article-title":"Preoperative observations and short-term outcome after partial external biliary diversion in 13 patients with progressive familial intrahepatic cholestasis","volume":"43","author":"Arnell","year":"2008","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jhep.2009.04.009_bib175","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0168-8278(01)00299-9","article-title":"Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum","volume":"36","author":"van Ooteghem","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib176","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/hep.20998","article-title":"Nasobiliary drainage induces long-lasting remission in benign recurrent intrahepatic cholestasis","volume":"43","author":"Stapelbroek","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib177","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1055\/s-2001-19036","article-title":"Alagille syndrome and the Jagged1 gene","volume":"21","author":"Piccoli","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2009.04.009_bib178","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"Benichou","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib179","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib180","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2009.04.009_bib181","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1021\/mp060133c","article-title":"Clinical hepatotoxicity. Regulation and treatment with inducers of transport and cofactors","volume":"4","author":"Marschall","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jhep.2009.04.009_bib182","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1097\/01.mcg.0000155548.91524.6e","article-title":"Drug-induced hepatotoxicity: 2005","volume":"39","author":"Maddrey","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib183","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-8278(97)82326-4","article-title":"Drug-induced cholestasis","volume":"26","author":"Erlinger","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib184","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2009.04.009_bib185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cld.2006.05.009","article-title":"Drug hepatotoxicity","volume":"10","author":"Nathwani","year":"2006","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.04.009_bib186","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.44.5.731","article-title":"The natural history of histologically proved drug induced liver disease","volume":"44","author":"Aithal","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.04.009_bib187","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0168-8278(97)82330-6","article-title":"Vanishing bile duct syndrome in drug-induced liver disease","volume":"26","author":"Desmet","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib188","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0168-8278(00)80139-7","article-title":"Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management","volume":"33","author":"Lammert","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib189","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-2-26","article-title":"Intrahepatic cholestasis of pregnancy","volume":"2","author":"Pusl","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2009.04.009_bib190","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/hep.20336","article-title":"Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates","volume":"40","author":"Glantz","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib191","unstructured":"Royal College of Obstetricians and Gynaecologists. Obstetric cholestasis. RCOG Guideline No. 43, 2006:1\u201310."},{"key":"10.1016\/j.jhep.2009.04.009_bib192","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1665-2681(19)32188-X","article-title":"Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid","volume":"1","author":"Brites","year":"2002","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib193","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0168-8278(97)80146-8","article-title":"Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo","volume":"27","author":"Palma","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib194","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1471-0528.2004.00167.x","article-title":"Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group","volume":"111","author":"Williamson","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.jhep.2009.04.009_bib195","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-2008-1078756","article-title":"Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy","volume":"25","author":"Lee","year":"2008","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib196","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/hep.22130","article-title":"Liver disease in pregnancy","volume":"47","author":"Hay","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib197","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.20952","article-title":"Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid","volume":"42","author":"Glantz","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib198","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.gastro.2005.06.019","article-title":"Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy","volume":"129","author":"Kondrackiene","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib199","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/JPM.2006.077","article-title":"Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of intrahepatic cholestasis of pregnancy","volume":"34","author":"Binder","year":"2006","journal-title":"J Perinat Med"},{"key":"10.1016\/j.jhep.2009.04.009_bib200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1471-0528.2003.00029.x","article-title":"A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis","volume":"111","author":"Roncaglia","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.jhep.2009.04.009_bib201","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/jhep.2001.22647","article-title":"Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers","volume":"33","author":"Mazzella","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib202","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1471-0528.2002.01368.x","article-title":"Obstetric cholestasis, outcome with active management: a series of 70 cases","volume":"109","author":"Kenyon","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.jhep.2009.04.009_bib203","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0301-2115(01)00463-8","article-title":"Obstetric cholestasis: outcome with active management","volume":"100","author":"Roncaglia","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jhep.2009.04.009_bib204","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/hep.20534","article-title":"Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy","volume":"41","author":"Ko","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib205","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0016-5107(04)01679-7","article-title":"Safety and efficacy of ERCP in pregnancy","volume":"60","author":"Kahaleh","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2009.04.009_bib206","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1572-0241.2003.07261.x","article-title":"Safety of ERCP during pregnancy","volume":"98","author":"Tham","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib207","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1053\/j.gastro.2007.06.002","article-title":"AGA Institute review of endoscopic sedation","volume":"133","author":"Cohen","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib208","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.gastro.2006.04.049","article-title":"American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy","volume":"131","author":"Mahadevan","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib209","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jhep.2004.08.029","article-title":"Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis","volume":"42","author":"Poupon","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib210","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1365-2036.2003.01792.x","article-title":"Systematic review: ursodeoxycholic acid\u2013adverse effects and drug interactions","volume":"18","author":"Hempfling","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.04.009_bib211","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"key":"10.1016\/j.jhep.2009.04.009_bib212","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.2165\/00003495-200262160-00004","article-title":"Immunosuppression in pregnancy: choices for infant and maternal health","volume":"62","author":"Armenti","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.jhep.2009.04.009_bib213","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/j.1572-0241.2004.30231.x","article-title":"Liver disease in pregnancy","volume":"99","author":"Benjaminov","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib214","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2165\/00003495-200868150-00006","article-title":"Pathogenesis and treatment of pruritus in cholestasis","volume":"68","author":"Kremer","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.jhep.2009.04.009_bib215","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0016-5085(66)80071-9","article-title":"Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis","volume":"50","author":"Datta","year":"1966","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib216","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2362.2000.00606.x","article-title":"Effect of cholestyramine on bile acid patterns and synthesis during administration of ursodeoxycholic acid in man","volume":"30","author":"Rust","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jhep.2009.04.009_bib217","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1478-3231.2006.01326.x","article-title":"Rifampin is safe for the treatment of pruritus die to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials","volume":"26","author":"Khurana","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2009.04.009_bib218","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1572-0241.2007.01200.x","article-title":"The efficacy and safety of bile acid binding agents, opioid antagonists or rifampicin in the treatment of cholestasis-associated pruritus","volume":"102","author":"Tandon","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib219","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib220","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/gut.50.3.436","article-title":"Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis","volume":"50","author":"Prince","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.04.009_bib221","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0016-5085(00)70225-3","article-title":"Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis","volume":"118","author":"Jones","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib222","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/qjmed\/95.8.547","article-title":"Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions","volume":"95","author":"Jones","year":"2002","journal-title":"Q J Med"},{"key":"10.1016\/j.jhep.2009.04.009_bib223","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","article-title":"Sertraline as a first-line treatment for cholestatic pruritus","volume":"45","author":"Mayo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib224","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1572-0241.2004.30204.x","article-title":"Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis","volume":"99","author":"Pares","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib225","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jhep.2006.08.008","article-title":"Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis","volume":"45","author":"Pusl","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib226","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1155\/2008\/969826","article-title":"Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: case reports","volume":"22","author":"Alallam","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib227","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.21271","article-title":"Biliary drainage transiently relieves intractable pruritus in primary biliary cirrhosis","volume":"44","author":"Beuers","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib228","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hep.510290229","article-title":"Quality of life before and after liver transplantation for cholestatic liver disease","volume":"29","author":"Gross","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib229","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jhep.2007.03.006","article-title":"Fatigue in cholestatic liver disease: is it all in the mind?","volume":"46","author":"Jones","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib230","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cgh.2007.11.021","article-title":"A predictive model for fatigue and its aetiologica associations in primary biliary cirrhosis","volume":"6","author":"Newton","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib231","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hep.21230","article-title":"Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence","volume":"44","author":"Newton","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib232","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2036.2006.03223.x","article-title":"An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis","volume":"25","author":"Jones","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.04.009_bib233","doi-asserted-by":"crossref","unstructured":"Ian Gan S, de Jongh M, Kaplan MM. Modafinil in the treatment of debilitating fatigue in primary biliary cirrhosis: a clinical experience. Dig Dis Sci 2008 Dec 12. [Epub ahead of print].","DOI":"10.1007\/s10620-008-0613-3"},{"key":"10.1016\/j.jhep.2009.04.009_bib234","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/qjmed\/hcn043","article-title":"An integrated care pathway improves quality of life in primary biliary cirrhosis","volume":"101","author":"Jones","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.jhep.2009.04.009_bib235","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cld.2008.02.005","article-title":"Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment","volume":"12","author":"Pares","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.04.009_bib236","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2036.2004.01890.x","article-title":"Transdermal hormone replacement therapy improves veretebral bone density in primary biliary cirrhosis: results of a 1-year controlled trial","volume":"19","author":"Pereira","year":"2004","journal-title":"Aliment Pharmacol Therap"},{"key":"10.1016\/j.jhep.2009.04.009_bib237","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10620-006-8015-x","article-title":"Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen\/progestin","volume":"51","author":"Boone","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2009.04.009_bib238","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1572-0241.2003.07639.x","article-title":"Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis","volume":"98","author":"Guanabens","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib239","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/00365520510023279","article-title":"Effects of alendronate on bone mass in patients with primary biliary cirrhosis and osteoporosis: preliminary results after one year","volume":"40","author":"Musialik","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.04.009_bib240","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0168-8278(92)90066-X","article-title":"Sodium fluoride prevents bone loss in primary biliary cirrhosis","volume":"15","author":"Guanabens","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.04.009_bib241","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1478-3231.2005.01026.x","article-title":"Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study","volume":"25","author":"Levy","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2009.04.009_bib242","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/gut.49.2.282","article-title":"Osteoporosis in primary biliary cirrhosis revisited","volume":"49","author":"Newton","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.04.009_bib243","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/0016-5085(89)90526-X","article-title":"Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival","volume":"96","author":"Gores","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.04.009_bib244","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.510260508","article-title":"Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes","volume":"26","author":"Jones","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib245","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib246","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.04.009_bib247","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/gut.2004.040832","article-title":"Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic creeening for oesophageal varices detection","volume":"54","author":"Bressler","year":"2005","journal-title":"Gut"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827809003092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827809003092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T09:05:36Z","timestamp":1589879136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827809003092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":247,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0168827809003092"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2009.04.009","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}